Vasculearn Network

Clot, Clot, Who's There?

Explore the world of thrombosis and hemostasis with "Clot Clot, Who's There?", a thought-provoking podcast brought to you by Vasculearn Network in collaboration with the Thrombosis and Haemostasis Editors (Thieme).

Vizitează neapărat site-ul podcastului și susține-i creatorul: sites.libsyn.com

Autor

Vasculearn Network

Categorie

Health

Site-ul podcastului

sites.libsyn.com

Cel mai nou episod

1 nov. 2026

Unde asculți?

Podcasturi în aplicație Replaio Radio În curând

Podcasturile ajung în curând în aplicație. Instaleaz-o acum și fii primul care descoperă o abordare complet nouă a podcasturilor

Descarcă din Google Play Instalează gratuit Android 10 mil.+ descărcări · nota 4,7+ iOS în curând

Episoade

What's Next in FXa Inhibitor Reversal? 01.11.2026

When your patient's seriously bleeding or surgery can't be delayed, what could the next generation of factor Xa inhibitor reversal therapies offer? Join experts Alex Spyropoulos, Lana Castellucci, and Gabe Fontaine as they break down: • Why more treatment options are needed • Different paths to restoring clotting • What PCC trials tell us • VMX-C001: A distinct approach under investigation • Why c...

Choosing Advanced PE Therapies: Evidence, Timing, and Technique From Risk Assessment to Treatment 09.10.2026

More tools. New evidence. Tough decisions. With the 2026 AHA/ACC pulmonary embolism (PE) guidelines as a backdrop, when is anticoagulation enough, and when is it time to reach for advanced therapy? Behnood Bikdeli, Jane Leopold, Lisa Moores, and Suresh Vedantham return to take on the treatment questions that follow risk assessment. From fibrinolysis and mechanical thrombectomy to extracorporeal me...

Reading the Risk: PE Stratification in 2026 A New Era in PE Care 09.10.2026

The blood pressure looks reassuring, but is it telling the whole story? In acute pulmonary embolism (PE), the next few hours can matter as much as the first set of vital signs. Behnood Bikdeli joins experts Jane Leopold, Lisa Moores, and Suresh Vedantham to unpack the 2026 AHA/ACC PE guidelines and put the new risk-stratification framework to work. With two patient cases and practical bedside insi...

The GLP-1 Question: What About Blood Clots? 17.09.2026

GLP-1s are transforming the treatment of diabetes and obesity, but could their benefits extend to venous thromboembolism (VTE)? And what should clinicians tell patients with a history of VTE? Join host Julia Sandrin Gauer and experts Christian Ruff and Rushad Patell as they discuss: • What current evidence suggests about GLP-1 therapies and VTE risk • The limitations of existing clinical trial and...

Is Anticoagulation Still on Board? Rapid FXa Assessment 01.08.2026

Your patient is bleeding or needs urgent surgery, but no one knows when the last DOAC dose was taken. Is there still enough factor Xa inhibitor on board to change what happens next? Join experts Alex Spyropoulos, Christopher Baugh, and Deborah Siegal as they discuss: • Why stabilization must come before laboratory confirmation • The limitations of routine coagulation tests • How to interpret drug-...

Bleeding vs. Clotting: The Periprocedural Tightrope in Patients on Factor Xa Inhibitors 01.08.2026

Factor Xa inhibitors have transformed anticoagulation, but urgent bleeding or surgery may require decisions before clinicians know when the last dose was taken or how much anticoagulant activity remains. Join experts Alex Spyropoulos, Eduardo Ramacciotti, and Preston Hewgley as they discuss: • Why residual factor Xa inhibitor activity matters in urgent care • How an unknown last dose complicates c...

The COBRRA Trial and the Questions that Remain 01.07.2026

The COBRRA Trial and the Questions that Remain Clinicians have long relied on indirect comparisons when choosing between direct oral anticoagulants (DOACs) for VTE. The COBRRA trial changed that. Join experts Behnood Bikdeli, Lana Castellucci, and David Jiménez as they discuss: • The landmark COBRRA trial and its implications for VTE treatment • How bleeding risk, adherence, and patient preference...

Thoracic Outlet Syndrome: Evidence vs. Experience 01.06.2026

When a young, otherwise healthy patient presents with an upper extremity DVT, venous thoracic outlet syndrome should be high on the differential—but the diagnosis is often delayed or missed. Join experts JoMarie Monzon, MSN, FNP-BC and Drs. Donna Bahroloomi, Ali Azizzadeh, and Vincent Jongkind as they discuss: Why venous thoracic outlet syndrome is frequently mistaken for musculoskeletal injury Di...

Inside the Lab: Bypassing Factor Xa Inhibitors 01.05.2026

In urgent, high-stakes situations—like major bleeding or emergency surgery—how should clinicians assess coagulation in patients on factor Xa inhibitors? And more importantly, are we focusing on the right signal? Join global experts as they explore: Why traditional assays (PT/aPTT, anti-Xa) often fall short in critical decision-making The role of functional testing in assessing true hemostatic pote...

Stopping the Second Stroke: Emerging Strategies in Secondary Prevention 01.04.2026

Surviving a stroke is only the beginning. Preventing the next one is where the real clinical challenge lies—and for patients with non-cardioembolic stroke, the existing toolkit has long fallen short. Join Drs. Geoff Barnes, Mike Sharma, and Valeria Caso as they explore: Stroke subtypes, recurrence risk, and the unique challenges of non-cardioembolic stroke and ESUS Why current treatment options ha...

Precision Over Prescription: Antithrombotic Therapy and CAD 02.03.2026

When it comes to antithrombotic therapy in coronary artery disease, the central question is no longer "What should everyone get?" It's "What's right for this patient?" In this episode, Drs. Heather Johnson, Ty Gluckman, and Davide Cappodano explore the modern balance between managing clotting and bleeding risk in patients on antiplatelets and anticoagulants. From the evolving role of aspirin and P...

AF Gone, Clot Still Knocking? 09.02.2026

In this episode of Clot, Clot, Who's There? Drs. Christian Ruff (USA) and Giulio Francesco Romiti (Italy) chat about long-term anticoagulation management after successful atrial fibrillation ablation. They explore why stroke risk may persist despite rhythm control, examine emerging evidence from the ALONE-AF and OCEAN trials, and consider how patient selection and shared decision-making should inf...

What's Clotting in 2026? 07.01.2026

In this episode of Clot Clot Who's There, Aviva Schwartz, Director of Education at Vasculearn Network, speaks with Professor Gregory Lip about key anticoagulation and atrial fibrillation data from 2025 and what lies ahead in 2026. The discussion spans post–AF ablation management, holistic AF care, and emerging factor XI inhibitors shaping the future of thrombosis management. Tune in now and subscr...

A Bridge Too Far? Navigating Perioperative Anticoagulation Challenges in Nonurgent Procedures 01.12.2025

Host Dr. Alex Spyropoulos is joined by global experts Drs. James Douketis and Marc Samama for a focused, practical discussion on perioperative anticoagulation management in nonurgent procedures. Together, they clarify: When and how to safely interrupt warfarin and direct oral anticoagulants Why heparin bridging is now rarely needed How procedural bleeding risk and pharmacokinetics inform decision-...

Antithrombotic Stewardship 30.10.2025

Host Tara Lech is joined by Drs. Scott Woller and Virginia Silvari for a thoughtful conversation on anticoagulation stewardship: what it is, why it matters, and how it can help patients who need antithrombotic therapy. They share examples from their own practice, talk through common challenges, and offer simple steps for improving care across settings. Topics: What makes anticoagulation stewardshi...

Recent Advances in Immunothrombosis & Thromboinflammation 29.09.2025

Join host Christian Weber, MD (LMU Munich) with vascular biology experts Kimberly Martinod, PhD (University of Rochester) and Konstantin Stark, MD (LMU Munich) as they explore the evolving science of immunothrombosis and thromboinflammation—concepts that rose to prominence during COVID-19 but reach far beyond infectious disease. Learn about: How thrombotic and inflammatory mechanisms impact cardio...

When Time is Limb: Acute Limb Ischemia and Thrombotic Emergencies 28.08.2025

Join JoMarie Monzon, NP (Cedars-Sinai, Vasculearn Network) as she welcomes moderator Dr. Cassra Arbabi and guests Drs. Donald Baril (Cedars-Sinai) and Efthymios (Makis) Avgerinos (Athens Medical Center) for a high-stakes discussion on acute limb ischemia (ALI). Explore U.S. and European approaches to this vascular emergency—from recognition to revascularization—and gain practical, globally informe...

Conversations that count: Communicating with patients about anticoagulation 24.06.2025

Dr. Bethany Samuelson Bannow is joined by Dr. Erik Klok and Dr. Geoff Barnes for a discussion on the best ways to communicate with your patients about anticoagulation. Anticoagulation therapy is a cornerstone of care for patients, but starting and managing these medications can be overwhelming for patients. In this episode, we'll cover common patient questions, tips for improving adherence, how to...

Global Rhythm: US and European Atrial Fibrillation Guidelines Head-to-Head 28.05.2025

Join Dr. Jose Joglar, Chair of the 2023 U.S. AFib Guidelines, and Professor Gregory Lip, Chair of the ESC Council on Stroke, as they dive into the latest U.S. and European atrial fibrillation guidelines. From risk scores to rhythm control, they explore common ground, key differences, and the global shift toward holistic, patient-centered care. (Hint: coffee lovers with AFib, rejoice!) Whether you'...

Risky Business: Stratifying VTE and Managing Anticoagulation 25.04.2025

Join host Dr. Kerstin de Wit as she welcomes Drs. Cecilia Becattini and Behnood Bikdeli to unpack one of the most nuanced challenges in thrombosis care: venous thromboembolism (VTE) risk stratification and anticoagulation management. This case-based conversation explores:  How clinicians navigate decisions around continuing, reducing, or stopping anticoagulation Whether formal risk scores or D-dim...

Sex as a Risk Factor for AF-related Stroke 19.02.2025

Does sex influence the risk of atrial fibrillation (AF)-related strokes? Is female sex truly an independent risk factor? And what common myths still cloud clinical understanding? In this episode, host Dr. Giulio Francesco Romiti ( internal medicine specialist from Sapienza University of Rome, Italy ) is joined by guests Dr. Geoff Barnes (cardiologist and vascular medicine specialist, University of...

The Burden of Atrial Fibrillation 29.01.2025

In this inaugural episode of Clot Clot Who's There , global experts Professor Tatjana Potpara (Serbia), and Dr. Annabelle Volgman (USA) join moderator Dr. Panteleimon Papakonstantinou (Ireland) to discuss the rising global prevalence of atrial fibrillation (AF), a leading contributor to strokes and heart failure. They explore regional differences in AF management, evolving guidelines, and the pote...

Ascultă podcastul Clot, Clot, Who's There? în Replaio

Radio și podcasturi într-o singură aplicație - gratuit și fără înregistrare. Instaleaz-o azi și nu rata lansarea

Descarcă din Google Play

Replaio nu este editorul podcasturilor; numele emisiunilor, coperțile și materialul audio aparțin autorilor lor și sunt distribuite prin fluxuri RSS publice